230 related articles for article (PubMed ID: 21674557)
21. Myofibroblasts and hepatocellular carcinoma: an in vivo and in vitro study.
Nhieu JT; Brochériou I; Préaux AM; Mallat A; Cherqui D; Zafrani ES; Mavier P
J Hepatol; 1998 Jul; 29(1):120-8. PubMed ID: 9696500
[TBL] [Abstract][Full Text] [Related]
22. Bone morphogenetic protein 4 provides cancer-supportive phenotypes to liver fibroblasts in patients with hepatocellular carcinoma.
Mano Y; Yoshio S; Shoji H; Tomonari S; Aoki Y; Aoyanagi N; Okamoto T; Matsuura Y; Osawa Y; Kimura K; Yugawa K; Wang H; Oda Y; Yoshizumi T; Maehara Y; Kanto T
J Gastroenterol; 2019 Nov; 54(11):1007-1018. PubMed ID: 30941514
[TBL] [Abstract][Full Text] [Related]
23. Hepatocellular carcinoma-associated mesenchymal stem cells promote hepatocarcinoma progression: role of the S100A4-miR155-SOCS1-MMP9 axis.
Yan XL; Jia YL; Chen L; Zeng Q; Zhou JN; Fu CJ; Chen HX; Yuan HF; Li ZW; Shi L; Xu YC; Wang JX; Zhang XM; He LJ; Zhai C; Yue W; Pei XT
Hepatology; 2013 Jun; 57(6):2274-86. PubMed ID: 23316018
[TBL] [Abstract][Full Text] [Related]
24. Arousal of cancer-associated stroma: overexpression of palladin activates fibroblasts to promote tumor invasion.
Brentnall TA; Lai LA; Coleman J; Bronner MP; Pan S; Chen R
PLoS One; 2012; 7(1):e30219. PubMed ID: 22291919
[TBL] [Abstract][Full Text] [Related]
25. Carcinoma-associated fibroblasts: non-neoplastic tumour-promoting mesenchymal cells.
Polanska UM; Orimo A
J Cell Physiol; 2013 Aug; 228(8):1651-7. PubMed ID: 23460038
[TBL] [Abstract][Full Text] [Related]
26. Cancer-associated fibroblasts contributed to hepatocellular carcinoma recurrence and metastasis via CD36-mediated fatty-acid metabolic reprogramming.
Wang H; Liu F; Wu X; Zhu G; Tang Z; Qu W; Zhao Q; Huang R; Tian M; Fang Y; Jiang X; Tao C; Gao J; Liu W; Zhou J; Fan J; Wu D; Shi Y
Exp Cell Res; 2024 Feb; 435(2):113947. PubMed ID: 38301989
[TBL] [Abstract][Full Text] [Related]
27. Reply: To PMID 21674557.
Mazzocca A; Giannelli G
Hepatology; 2013 Jan; 57(1):418-9. PubMed ID: 22707239
[No Abstract] [Full Text] [Related]
28. Cancer-associated fibroblasts in hepatocellular carcinoma.
Kubo N; Araki K; Kuwano H; Shirabe K
World J Gastroenterol; 2016 Aug; 22(30):6841-50. PubMed ID: 27570421
[TBL] [Abstract][Full Text] [Related]
29. Mutual paracrine effects of oral squamous cell carcinoma cells and normal oral fibroblasts: induction of fibroblast to myofibroblast transdifferentiation and modulation of tumor cell proliferation.
Kellermann MG; Sobral LM; da Silva SD; Zecchin KG; Graner E; Lopes MA; Kowalski LP; Coletta RD
Oral Oncol; 2008 May; 44(5):509-17. PubMed ID: 17826300
[TBL] [Abstract][Full Text] [Related]
30. Down-regulation of connective tissue growth factor by inhibition of transforming growth factor beta blocks the tumor-stroma cross-talk and tumor progression in hepatocellular carcinoma.
Mazzocca A; Fransvea E; Dituri F; Lupo L; Antonaci S; Giannelli G
Hepatology; 2010 Feb; 51(2):523-34. PubMed ID: 19821534
[TBL] [Abstract][Full Text] [Related]
31. Human hepatic myofibroblasts increase invasiveness of hepatocellular carcinoma cells: evidence for a role of hepatocyte growth factor.
Neaud V; Faouzi S; Guirouilh J; Le Bail B; Balabaud C; Bioulac-Sage P; Rosenbaum J
Hepatology; 1997 Dec; 26(6):1458-66. PubMed ID: 9397985
[TBL] [Abstract][Full Text] [Related]
32. Lysophospholipid variants in hepatocellular carcinoma.
Skill NJ; Jianmin W; Yan X; Zhao Z; Tector AJ; Maluccio MA
J Surg Res; 2013 Jun; 182(2):241-9. PubMed ID: 23158405
[TBL] [Abstract][Full Text] [Related]
33. 22 : 6n-3 DHA inhibits differentiation of prostate fibroblasts into myofibroblasts and tumorigenesis.
Bianchini F; Giannoni E; Serni S; Chiarugi P; Calorini L
Br J Nutr; 2012 Dec; 108(12):2129-37. PubMed ID: 22390897
[TBL] [Abstract][Full Text] [Related]
34. Membrane-to-Nucleus Signals and Epigenetic Mechanisms for Myofibroblastic Activation and Desmoplastic Stroma: Potential Therapeutic Targets for Liver Metastasis?
Kang N; Shah VH; Urrutia R
Mol Cancer Res; 2015 Apr; 13(4):604-12. PubMed ID: 25548101
[TBL] [Abstract][Full Text] [Related]
35. Hepatocyte autotaxin expression promotes liver fibrosis and cancer.
Kaffe E; Katsifa A; Xylourgidis N; Ninou I; Zannikou M; Harokopos V; Foka P; Dimitriadis A; Evangelou K; Moulas AN; Georgopoulou U; Gorgoulis VG; Dalekos GN; Aidinis V
Hepatology; 2017 Apr; 65(4):1369-1383. PubMed ID: 27981605
[TBL] [Abstract][Full Text] [Related]
36. Lipocalin-2 negatively modulates the epithelial-to-mesenchymal transition in hepatocellular carcinoma through the epidermal growth factor (TGF-beta1)/Lcn2/Twist1 pathway.
Wang YP; Yu GR; Lee MJ; Lee SY; Chu IS; Leem SH; Kim DG
Hepatology; 2013 Oct; 58(4):1349-61. PubMed ID: 23696034
[TBL] [Abstract][Full Text] [Related]
37. Osteonectin/SPARC is overexpressed in human hepatocellular carcinoma.
Le Bail B; Faouzi S; Boussarie L; Guirouilh J; Blanc JF; Carles J; Bioulac-Sage P; Balabaud C; Rosenbaum J
J Pathol; 1999 Sep; 189(1):46-52. PubMed ID: 10451487
[TBL] [Abstract][Full Text] [Related]
38. Tumor stroma with senescence-associated secretory phenotype in steatohepatitic hepatocellular carcinoma.
Lee JS; Yoo JE; Kim H; Rhee H; Koh MJ; Nahm JH; Choi JS; Lee KH; Park YN
PLoS One; 2017; 12(3):e0171922. PubMed ID: 28273155
[TBL] [Abstract][Full Text] [Related]
39. Disruption of a regulatory loop between DUSP1 and p53 contributes to hepatocellular carcinoma development and progression.
Hao PP; Li H; Lee MJ; Wang YP; Kim JH; Yu GR; Lee SY; Leem SH; Jang KY; Kim DG
J Hepatol; 2015 Jun; 62(6):1278-86. PubMed ID: 25617504
[TBL] [Abstract][Full Text] [Related]
40. Lysophosphatidic acid aberrancies and hepatocellular carcinoma: studies in the MDR2 gene knockout mouse.
Skill N; Wu J; Xu Y; Zhao Z; Maluccio M
Cancer Invest; 2013 Feb; 31(2):145-55. PubMed ID: 23362952
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
